SCHEMBL4537535

SCHEMBL4537535

Cn1ncnc1-c1ccc(C(=O)NC(Cc2ccccc2)C(NC(=O)O)C(C)(C)C)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 7/20 0.41
HDAC1 Q13547 6/20 0.36
HDAC3 O15379 4/20 0.36
HDAC4 P56524 4/20 0.36
HDAC7 Q8WUI4 4/20 0.36
HDAC2 Q92769 4/20 0.36
HDAC10 Q969S8 4/20 0.36
HDAC11 Q96DB2 4/20 0.36
HDAC8 Q9BY41 4/20 0.36
HDAC6 Q9UBN7 4/20 0.36
HDAC9 Q9UKV0 4/20 0.36
HDAC5 Q9UQL6 4/20 0.36
CTSL P07711 2/20 0.35
AKT3 Q9Y243 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
CYP3A4 P08684 1/20 0.34
CCR1 P32246 1/20 0.34
CTSB P07858 1/20 0.34
CTSS P25774 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1529421 0.82 HPGDS (0.43) HPGDSHDAC1HDAC3HDAC4HDAC7
SCHEMBL4544034 0.81 HPGDS (0.38) HPGDSHDAC1HDAC3HDAC4HDAC7
SCHEMBL4543913 0.80 HPGDS (0.36) HPGDSHDAC1HDAC3HDAC4HDAC7
SCHEMBL1529579 0.79 HPGDS (0.41) HPGDSHDAC1HDAC3HDAC4HDAC7
SCHEMBL4382189 0.78 ACKR3 (0.43) HDAC1HDAC3HDAC4CTSL
SCHEMBL4375386 0.78 ACKR3 (0.43) HDAC1HDAC3HDAC4CTSL
SCHEMBL12679256 0.78 ATM (0.45) HPGDSCTSLDYRK1ADYRK1BCTSB
SCHEMBL4592997 0.76 AKT1 (0.43) HPGDSAKT3DYRK1ADYRK1B
SCHEMBL4542245 0.75 AKT1 (0.39) HDAC8CTSLCTSBCTSS
SCHEMBL4378512 0.74 AKT1 (0.40) AKT3CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117523-A1 INHIBITORS OF AKT ACTIVITY SmithKline Beecham Corporation (US) 2009-11-18 EP disclosed
WO-2008098104-A1 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-08-14 WO disclosed